Kainate receptor signaling in pain pathways

Molecular Pharmacology

Volumn 83, Issue 2, 2013, Pages 307-315

  Bhangoo, Sonia K ^a   Swanson, Geoffrey T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [5 (4 DIMETHYLSULFAMOYLPHENYL) 6,7,8,9 TETRAHYDRO 8 METHYL 2 OXO 1H PYRROLO[3,2 H]ISOQUINOLIN 3 YLIMINOXY] 4 HYDROXYBUTYRIC ACID; 4 AMINOBUTYRIC ACID; 4 METHYLGLUTAMIC ACID; 6 (4 CARBOXYBENZYL) 1,2,3,4,4A,5,6,7,8,8A DECAHYDRO 3 ISOQUINOLINECARBOXYLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 5 TERT BUTYL 3 HYDROXY 4 ISOXAZOLEPROPIONIC ACID; ANALGESIC AGENT; DECAHYDROISOQUINOLINE DERIVATIVE; GLUTAMIC ACID; ISOQUINOLINE DERIVATIVE; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; MESSENGER RNA; TEZAMPANEL; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

4 AMINOBUTYRIC ACID RELEASE; ANALGESIC ACTIVITY; CHRONIC PAIN; DRUG EFFICACY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REVIEW; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL GANGLION; SYMPATHETIC INNERVATION; THALAMUS;

ANALGESICS; ANIMALS; CHRONIC PAIN; HUMANS; RECEPTORS, KAINIC ACID; SIGNAL TRANSDUCTION;

EID: 84872715977     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.081398     Document Type: Review

References (136)

1. Agrawal SG and Evans RH (1986) The primary afferent depolarizing action of kainate in the rat. Br J Pharmacol 87:345-355.
2. Andreou AP and Goadsby PJ (2011) Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway. Cephalalgia 31:1343-1358.
3. Andreou AP, Holland PR, and Goadsby PJ (2009) Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation. Br J Pharmacol 157:464-473.
4. Apkarian AV, Bushnell MC, Treede RD, and Zubieta JK (2005) Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9: 463-484.
5. Ault B and Hildebrand LM (1993) Activation of nociceptive reflexes by peripheral kainate receptors. J Pharmacol Exp Ther 265:927-932.
6. Baba H, Ji RR, Kohno T, Moore KA, Ataka T, Wakai A, Okamoto M, and Woolf CJ (2003) Removal of GABAergic inhibition facilitates polysynaptic A fiber-mediated excitatory transmission to the superficial spinal dorsal horn. Mol Cell Neurosci 24: 818-830.
7. Bahn S, Volk B, and Wisden W (1994) Kainate receptor gene expression in the developing rat brain. J Neurosci 14:5525-5547.
8. Basbaum AI, Bautista DM, Scherrer G, and Julius D (2009) Cellular and molecular mechanisms of pain. Cell 139:267-284.
9. Bettler B, Boulter J, Hermans-Borgmeyer I, O'Shea-Greenfield A, Deneris ES, Moll C, Borgmeyer U, Hollmann M, and Heinemann S (1990) Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron 5:583-595.
10. Binns KE, Turner JP, and Salt TE (2003) Kainate receptor (GluR5)-mediated disinhibition of responses in rat ventrobasal thalamus allows a novel sensory processing mechanism. J Physiol 551:525-537.
11. Bleakman R, Schoepp DD, Ballyk B, Bufton H, Sharpe EF, Thomas K, Ornstein PL, and Kamboj RK (1996) Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl] decahyd roisdoquinoline-3 carboxylic-acid. Mol Pharmacol 49:581-585.
12. Braga MF, Aroniadou-Anderjaska V, Li H, and Rogawski MA (2009) Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. J Pharmacol Exp Ther 330:558-566.
13. Carlton SM and Coggeshall RE (1999) Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res 820:63-70.
14. Carlton SM, Hargett GL, and Coggeshall RE (1995) Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci Lett 197:25-28.
15. Carr PA and Nagy JI (1993) Emerging relationships between cytochemical properties and sensory modality transmission in primary sensory neurons. Brain Res Bull 30: 209-219.
16. Carrasquillo Y and Gereau RW (2008) Pain Sensitization, in Molecular Mechanisms of Memory (Sweatt JD ed) pp 65-90, Elsevier, Amsterdam, The Netherlands.
17. Castillo PE, Malenka RC, and Nicoll RA (1997) Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature 388:182-186.
18. Childers WE, Jr and Baudy RB (2007) N-methyl-D-aspartate antagonists and neuropathic pain: the search for relief. J Med Chem 50:2557-2562.
19. Chizh BA, Headley PM, and Tzschentke TM (2001) NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol Sci 22:636-642.
20. Christensen JK, Varming T, Ahring PK, Jørgensen TD, and Nielsen EO (2004) In vitro characterization of 5-carboxyl-2,4-di-benzamidobenzoic acid (NS3763), a noncompetitive antagonist of GLUK5 receptors. J Pharmacol Exp Ther 309:1003-1010.
21. Clarke VR, Ballyk BA, Hoo KH, Mandelzys A, and Pellizzari ABath CP, Thomas J, Sharpe EF, Davies CH, and Ornstein PL et al. (1997) A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389:599-603.
22. Coggeshall RE and Carlton SM (1998) Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery. J Comp Neurol 391:78-86.
23. Contractor A, Mulle C, and Swanson GT (2011) Kainate receptors coming of age: milestones of two decades of research. Trends Neurosci 34:154-163.
24. Contractor A, Swanson G, and Heinemann SF (2001) Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus. Neuron 29:209-216.
25. Contractor A, Swanson GT, Sailer A, O'Gorman S, and Heinemann SF (2000) Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus. J Neurosci 20: 8269-8278.
26. Copits BA and Swanson GT (2012) Dancing partners at the synapse: auxiliary subunits that shape kainate receptor function. Nat Rev Neurosci 13:675-686.
27. Cossart R, Esclapez M, Hirsch JC, Bernard C, and Ben-Ari Y (1998) GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells. Nat Neurosci 1:470-478.
28. Costigan M, Scholz J, and Woolf CJ (2009) Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 32:1-32.
29. Dahlhaus A, Ruscheweyh R, and Sandkühler J (2005) Synaptic input of rat spinal lamina I projection and unidentified neurones in vitro. J Physiol 566:355-368.
30. Dai WM, Christensen KV, Egebjerg J, Ebert B, and Lambert JD (2002) Correlation of the expression of kainate receptor subtypes to responses evoked in cultured cortical and spinal cord neurones. Brain Res 926:94-107.
31. Dargan SL, Clarke VR, Alushin GM, Sherwood JL, Nisticò R, Bortolotto ZA, Ogden AM, Bleakman D, Doherty AJ, and Lodge D et al. (2009) ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre function. Neuropharmacology 56:121-130.
32. Davies J, Evans RH, Francis AA, and Watkins JC (1979) Excitatory amino acid receptors and synaptic excitation in the mammalian central nervous system. J Physiol (Paris) 75:641-654.
33. Dodd J and Jessell TM (1985) Lactoseries carbohydrates specify subsets of dorsal root ganglion neurons projecting to the superficial dorsal horn of rat spinal cord. J Neurosci 5:3278-3294.
34. Dodd J and Jessell TM (1986) Cell surface glycoconjugates and carbohydrate-binding proteins: possible recognition signals in sensory neurone development. J Exp Biol 124:225-238.
35. Dolman NP, Troop HM, More JC, Alt A, Knauss JL, Nistico R, Jack S, Morley RM, Bortolotto ZA, and Roberts PJ et al. (2005) Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors. J Med Chem 48:7867-7881.
36. Dominguez E, Iyengar S, Shannon HE, Bleakman D, Alt A, Arnold BM, Bell MG, Bleisch TJ, Buckmaster JL, and Castano AM et al. (2005) Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain. J Med Chem 48:4200-4203.
37. Du J, Zhou S, and Carlton SM (2006) Kainate-induced excitation and sensitization of nociceptors in normal and inflamed rat glabrous skin. Neuroscience 137:999-1013.
38. Eder M, Becker K, Rammes G, Schierloh A, Azad SC, Zieglgänsberger W, and Dodt HU (2003) Distribution and properties of functional postsynaptic kainate receptors on neocortical layer V pyramidal neurons. J Neurosci 23:6660-6670.
39. Fang X, Djouhri L, McMullan S, Berry C, Waxman SG, Okuse K, and Lawson SN (2006) Intense isolectin-B4 binding in rat dorsal root ganglion neurons distinguishes C-fiber nociceptors with broad action potentials and high Nav1.9 expression. J Neurosci 26:7281-7292.
40. Filla SA, Winter MA, Johnson KW, Bleakman D, Bell MG, Bleisch TJ, Castaño AM, Clemens-Smith A, del Prado M, and Dieckman DK et al. (2002) Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar-bonylimidazol-1-ylmethyl)decahydroiso- quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine. J Med Chem 45:4383-4386.
41. Frerking M and Ohliger-Frerking P (2002) AMPA receptors and kainate receptors encode different features of afferent activity. J Neurosci 22:7434-7443.
42. Gerke MB and Plenderleith MB (2001) Binding sites for the plant lectin Bandeiraea simplicifolia I-isolectin B(4) are expressed by nociceptive primary sensory neurones. Brain Res 911:101-104.
43. Gilron I, Max MB, Lee G, Booher SL, Sang CN, Chappell AS, and Dionne RA (2000) Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain. Clin Pharmacol Ther 68:320-327.
44. Gryder DS and Rogawski MA (2003) Selective antagonism of GluR5 kainate-receptormediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci 23:7069-7074.
45. Hansen KB, Ogden KK, and Traynelis SF (2012) Subunit-selective allosteric inhibition of glycine binding to NMDA receptors. J Neurosci 32:6197-6208.
46. Herb A, Burnashev N, Werner P, Sakmann B, Wisden W, and Seeburg PH (1992) The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron 8:775-785.
47. Hjerling-Leffler J, Alqatari M, Ernfors P, and Koltzenburg M (2007) Emergence of functional sensory subtypes as defined by transient receptor potential channel expression. J Neurosci 27:2435-2443.
48. Huettner JE (1990) Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron 5:255-266.
49. Huettner JE (2003) Kainate receptors and synaptic transmission. Prog Neurobiol 70: 387-407.
50. Hunter JC and Singh L (1994) Role of excitatory amino acid receptors in the mediation of the nociceptive response to formalin in the rat. Neurosci Lett 174:217-221.
51. Hwang SJ, Pagliardini S, Rustioni A, and Valtschanoff JG (2001) Presynaptic kainate receptors in primary afferents to the superficial laminae of the rat spinal cord. J Comp Neurol 436:275-289.
52. Ibrahim HM, Healy DJ, Hogg AJ, Jr, and Meador-Woodruff JH (2000) Nucleusspecific expression of ionotropic glutamate receptor subunit mRNAs and binding sites in primate thalamus. Brain Res Mol Brain Res 79:1-17.
53. Jackson DL, Graff CB, Richardson JD, and Hargreaves KM (1995) Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur J Pharmacol 284:321-325.
54. Jane DE, Lodge D, and Collingridge GL (2009) Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology 56:90-113.
55. Janssen SP, Truin M, Van Kleef M, and Joosten EA (2011) Differential GABAergic disinhibition during the development of painful peripheral neuropathy. Neuroscience 184:183-194.
56. Jones CK, Alt A, Ogden AM, Bleakman D, Simmons RM, Iyengar S, Dominguez E, Ornstein PL, and Shannon HE (2006) Antiallodynic and antihyperalgesic effects of selective competitive GLUK5 (GluR5) ionotropic glutamate receptor antagonists in the capsaicin and carrageenan models in rats. J Pharmacol Exp Ther 319:396-404.
57. Jouhanneau JS, Ball SM, Molnár E, and Isaac JT (2011) Mechanisms of bidirectional modulation of thalamocortical transmission in barrel cortex by presynaptic kainate receptors. Neuropharmacology 60:832-841.
58. Julius D and Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413: 203-210.
59. Kamiya H and Ozawa S (2000) Kainate receptor-mediated presynaptic inhibition at the mouse hippocampal mossy fibre synapse. J Physiol 523:653-665.
60. Kerchner GA, Wang GD, Qiu CS, Huettner JE, and Zhuo M (2001a) Direct presynaptic regulation of GABA/glycine release by kainate receptors in the dorsal horn: an ionotropic mechanism. Neuron 32:477-488.
61. Kerchner GA, Wilding TJ, Huettner JE, and Zhuo M (2002) Kainate receptor subunits underlying presynaptic regulation of transmitter release in the dorsal horn. J Neurosci 22:8010-8017.
62. Kerchner GA, Wilding TJ, Li P, Zhuo M, and Huettner JE (2001b) Presynaptic kainate receptors regulate spinal sensory transmission. J Neurosci 21:59-66.
63. Kidd FL, Coumis U, Collingridge GL, Crabtree JW, and Isaac JT (2002) A presynaptic kainate receptor is involved in regulating the dynamic properties of thalamocortical synapses during development. Neuron 34:635-646.
64. Kidd FL and Isaac JT (1999) Developmental and activity-dependent regulation of kainate receptors at thalamocortical synapses. Nature 400:569-573.
65. Ko S, Zhao MG, Toyoda H, Qiu CS, and Zhuo M (2005) Altered behavioral responses to noxious stimuli and fear in glutamate receptor 5 (GluR5)- or GluR6-deficient mice. J Neurosci 25:977-984.
66. Koga K, Sim SE, Chen T, Wu LJ, Kaang BK, and Zhuo M (2012) Kainate receptormediated synaptic transmissions in the adult rodent insular cortex. J Neurophysiol 108:1988-1998.
67. Latremoliere A and Woolf CJ (2009) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10:895-926.
68. Lee CJ, Bardoni R, Tong CK, Engelman HS, Joseph DJ, Magherini PC, and MacDermott AB (2002) Functional expression of AMPA receptors on central terminals of rat dorsal root ganglion neurons and presynaptic inhibition of glutamate release. Neuron 35:135-146.
69. Lee CJ, Kong H, Manzini MC, Albuquerque C, Chao MV, and MacDermott AB (2001) Kainate receptors expressed by a subpopulation of developing nociceptors rapidly switch from high to low Ca2+ permeability. J Neurosci 21:4572-4581.
70. Lee HJ, Pogatzki-Zahn EM, and Brennan TJ (2006) The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain. J Pain 7: 768-777.
71. Lerma J (2006) Kainate receptor physiology. Curr Opin Pharmacol 6:89-97.
72. Li P, Wilding TJ, Kim SJ, Calejesan AA, Huettner JE, and Zhuo M (1999) Kainate-receptormediated sensory synaptic transmission in mammalian spinal cord. Nature 397:161-164.
73. Li XY, Ko HG, Chen T, Descalzi G, Koga K, Wang H, Kim SS, Shang Y, Kwak C, and Park SW et al. (2010) Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 330:1400-1404.
74. Liu H, Wang H, Sheng M, Jan LY, Jan YN, and Basbaum AI (1994) Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci USA 91:8383-8387.
75. Lodge D (2009) The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology 56:6-21.
76. Metz AE, Yau HJ, Centeno MV, Apkarian AV, and Martina M (2009) Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain. Proc Natl Acad Sci USA 106:2423-2428.
77. Miller KE, Hoffman EM, Sutharshan M, and Schechter R (2011) Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther 130:283-309.
78. Miyata M and Imoto K (2006) Different composition of glutamate receptors in corticothalamic and lemniscal synaptic responses and their roles in the firing responses of ventrobasal thalamic neurons in juvenile mice. J Physiol 575:161-174.
79. Miyata M and Imoto K (2009) Contrary roles of kainate receptors in transmitter release at corticothalamic synapses onto thalamic relay and reticular neurons. J Physiol 587:999-1012.
80. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, and Woolf CJ (2002) Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22:6724-6731.
81. Mulle C, Sailer A, Swanson GT, Brana C, O'Gorman S, Bettler B, and Heinemann SF (2000) Subunit composition of kainate receptors in hippocampal interneurons. Neuron 28:475-484.
82. Murphy MF, Mellberg SJ, Kurtz NM, and Graham EA (2008) AMPA/Kainate receptor antagonist tezampanel is effective in treating acute migraine. Headache 48 (Suppl 1):S8.
83. Nagy JI and Hunt SP (1982) Fluoride-resistant acid phosphatase-containing neurones in dorsal root ganglia are separate from those containing substance P or somatostatin. Neuroscience 7:89-97.
84. Nakamura M, Choi KH, Choi SK, Do CS, Jun JH, Kwon HK, Lee SM, Moon RJ, Yi KJ, and Jang IS (2010) Presynaptic kainate receptors increase GABAergic neurotransmission in rat periaqueductal gray neurons. Eur J Pharmacol 635:72-78.
85. O'Neill MJ, Bond A, Ornstein PL, Ward MA, Hicks CA, Hoo K, Bleakman D, and Lodge D (1998) Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology 37:1211-1222.
86. Ogden KK and Traynelis SF (2011) New advances in NMDA receptor pharmacology. Trends Pharmacol Sci 32:726-733.
87. Palecek J, Neugebauer V, Carlton SM, Iyengar S, and Willis WD (2004) The effect of a kainate GluR5 receptor antagonist on responses of spinothalamic tract neurons in a model of peripheral neuropathy in primates. Pain 111:151-161.
88. Parsons CG, Danysz W, and Quack G (1998) Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect 11:523-569.
89. Partin KM, Patneau DK, Winters CA, Mayer ML, and Buonanno A (1993) Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11:1069-1082.
90. Paternain AV, Morales M, and Lerma J (1995) Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14:185-189.
91. Perrais D, Veran J, and Mulle C (2010) Gating and permeation of kainate receptors: differences unveiled. Trends Pharmacol Sci 31:516-522.
92. Petralia RS, Wang YX, and Wenthold RJ (1994) Histological and ultrastructural localization of the kainate receptor subunits, KA2 and GluR6/7, in the rat nervous system using selective antipeptide antibodies. J Comp Neurol 349:85-110.
93. Pfau DB, Klein T, Putzer D, Pogatzki-Zahn EM, Treede RD, and Magerl W (2011) Analysis of hyperalgesia time courses in humans after painful electrical highfrequency stimulation identifies a possible transition from early to late LTP-like pain plasticity. Pain 152:1532-1539.
94. Qiu CS, Lash-Van Wyhe L, Sasaki M, Sakai R, Swanson GT, and Gereau RW, 4th (2011) Antinociceptive effects of MSVIII-19, a functional antagonist of the GluK1 kainate receptor. Pain 152:1052-1060.
95. Rozas JL, Paternain AV, and Lerma J (2003) Noncanonical signaling by ionotropic kainate receptors. Neuron 39:543-553.
96. Sachidhanandam S, Blanchet C, Jeantet Y, Cho YH, and Mulle C (2009) Kainate receptors act as conditional amplifiers of spike transmission at hippocampal mossy fiber synapses. J Neurosci 29:5000-5008.
97. Sahara Y, Noro N, Iida Y, Soma K, and Nakamura Y (1997) Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons. J Neurosci 17:6611-6620.
98. Salt TE (2002) Glutamate receptor functions in sensory relay in the thalamus. Philos Trans R Soc Lond B Biol Sci 357:1759-1766.
99. Sanders JM, Ito K, Settimo L, Pentikäinen OT, Shoji M, Sasaki M, Johnson MS, Sakai R, and Swanson GT (2005) Divergent pharmacological activity of novel marine-derived excitatory amino acids on glutamate receptors. J Pharmacol Exp Ther 314:1068-1078.
100. Sang CN, Hostetter MP, Gracely RH, Chappell AS, Schoepp DD, Lee G, Whitcup S, Caruso R, and Max MB (1998) AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans. Anesthesiology 89:1060-1067.
101. Sang CN, Ramadan NM, Wallihan RG, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Johnson KW, Phebus LA, Bleakman D, and et al. (2004) LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia 24:596-602.
102. Sato K, Kiyama H, Park HT, and Tohyama M (1993) AMPA, KA and NMDA receptors are expressed in the rat DRG neurones. Neuroreport 4:1263-1265.
103. Schmitz D, Frerking M, and Nicoll RA (2000) Synaptic activation of presynaptic kainate receptors on hippocampal mossy fiber synapses. Neuron 27:327-338.
104. Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR, Moore KA, Decosterd I, Coggeshall RE, and Woolf CJ (2005) Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 25:7317-7323.
105. Seal RP, Wang X, Guan Y, Raja SN, Woodbury CJ, Basbaum AI, and Edwards RH (2009) Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors. Nature 462:651-655.
106. Sheffler DJ, Gregory KJ, Rook JM, and Conn PJ (2011) Allosteric modulation of metabotropic glutamate receptors. Adv Pharmacol 62:37-77.
107. Simmons RM, Li DL, Hoo KH, Deverill M, Ornstein PL, and Iyengar S (1998) Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology 37:25-36.
108. A and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. J Neurophysiol 72:169-179.
109. Sommer B, Burnashev N, Verdoorn TA, Keinänen K, Sakmann B, and Seeburg PH (1992) A glutamate receptor channel with high affinity for domoate and kainate. EMBO J 11:1651-1656.
110. Stanfa LC and Dickenson AH (1999) The role of non-N-methyl-D-aspartate ionotropic glutamate receptors in the spinal transmission of nociception in normal animals and animals with carrageenan inflammation. Neuroscience 93:1391-1398.
111. Stucky CL and Lewin GR (1999) Isolectin B(4)-positive and -negative nociceptors are functionally distinct. J Neurosci 19:6497-6505.
112. Sutton JL, Maccecchini ML, and Kajander KC (1999) The kainate receptor antagonist 2S,4R-4-methylglutamate attenuates mechanical allodynia and thermal hyperalgesia in a rat model of nerve injury. Neuroscience 91:283-292.
113. Swanson GT, Green T, and Heinemann SF (1998) Kainate receptors exhibit differential sensitivities to (S)-5-iodowillardiine. Mol Pharmacol 53:942-949.
114. Swanson GT and Heinemann SF (1998) Heterogeneity of homomeric GluR5 kainate receptor desensitization expressed in HEK293 cells. J Physiol 513:639-646.
115. Szekely JI, Torok K, and Mate G (2002) The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites. Curr Pharm Des 8: 887-912.
116. Ta LE, Dionne RA, Fricton JR, Hodges JS, and Kajander KC (2000) SYM-2081 a kainate receptor antagonist reduces allodynia and hyperalgesia in a freeze injury model of neuropathic pain. Brain Res 858:106-120.
117. Teichert RW, Smith NJ, Raghuraman S, Yoshikami D, Light AR, and Olivera BM (2012) Functional profiling of neurons through cellular neuropharmacology. Proc Natl Acad Sci USA 109:1388-1395.
118. Tölle TR, Berthele A, Zieglgänsberger W, Seeburg PH, and Wisden W (1993) The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci 13:5009-5028.
119. Tomita S and Castillo PE (2012) Neto1 and Neto2: auxiliary subunits that determine key properties of native kainate receptors. J Physiol 590:2217-2223.
120. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, and Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405-496.
121. Turner MS, Hamamoto DT, Hodges JS, Maccecchini ML, and Simone DA (2003) SYM 2081, an agonist that desensitizes kainate receptors, attenuates capsaicin and inflammatory hyperalgesia. Brain Res 973:252-264.
122. Valgeirsson J, Nielsen EO, Peters D, Mathiesen C, Kristensen AS, and Madsen U (2004) Bioisosteric modifications of 2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5. J Med Chem 47:6948-6957.
123. Valgeirsson J, Nielsen EO, Peters D, Varming T, Mathiesen C, Kristensen AS, and Madsen U (2003) 2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5. J Med Chem 46: 5834-5843.
124. Vignes M and Collingridge GL (1997) The synaptic activation of kainate receptors. Nature 388:179-182.
125. Vogt BA and Sikes RW (2000) The medial pain system, cingulate cortex, and parallel processing of nociceptive information. Prog Brain Res 122:223-235.
126. von Hehn CA, Baron R, and Woolf CJ (2012) Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 73:638-652.
127. Weiss B, Alt A, Ogden AM, Gates M, Dieckman DK, Clemens-Smith A, Ho KH, Jarvie K, Rizkalla G, and Wright RA et al. (2006) Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo. J Pharmacol Exp Ther 318:772-781.
128. Wilding TJ and Huettner JE (2001) Functional diversity and developmental changes in rat neuronal kainate receptors. J Physiol 532:411-421.
129. Wisden W and Seeburg PH (1993) A complex mosaic of high-affinity kainate receptors in rat brain. J Neurosci 13:3582-3598.
130. Wong LA and Mayer ML (1993) Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid- and kainate-preferring glutamate receptors. Mol Pharmacol 44:504-510.
131. Wong LA, Mayer ML, Jane DE, and Watkins JC (1994) Willardiines differentiate agonist binding sites for kainate-versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons. J Neurosci 14:3881-3897.
132. Woolf CJ (2011) Central sensitization: implications for the diagnosis and treatment of pain. Pain 152(3, Suppl)S2-S15.
133. Wu LJ, Ko SW, and Zhuo M (2007a) Kainate receptors and pain: from dorsal root ganglion to the anterior cingulate cortex. Curr Pharm Des 13:1597-1605.
134. Wu LJ, Xu H, Ren M, and Zhuo M (2007b) Genetic and pharmacological studies of GluR5 modulation of inhibitory synaptic transmission in the anterior cingulate cortex of adult mice. Dev Neurobiol 67:146-157.
135. Wu LJ, Zhao MG, Toyoda H, Ko SW, and Zhuo M (2005) Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. J Neurophysiol 94:1805-1813.
136. Youn DH and Randic M (2004) Modulation of excitatory synaptic transmission in the spinal substantia gelatinosa of mice deficient in the kainate receptor GluR5 and/or GluR6 subunit. J Physiol 555:683-698.